Kintara Therapeutics Inc (NASDAQ:KTRA)

0.4232
Delayed Data
As of 7:37pm ET
 -0.0301 / -6.64%
Today’s Change
0.42
Today|||52-Week Range
3.35
-17.02%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Kintara Therapeutics Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +1,199.62% increase from the last price of 0.42.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Kintara Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$0.00
Reporting Date
Feb 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.00%
 
 
 
 
 
 
Growthannually 63.54%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.